Danske Bank A S Takes Position in Centene Corporation $CNC

Posted by Stanley Muller on Aug 21st, 2026

Danske Bank A S bought a new position in Centene Corporation (NYSE:CNC – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 253,698 shares of the company’s stock, valued at approximately $16,285,000. Danske Bank A S owned about 0.05% of Centene at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. 180 Wealth Advisors LLC raised its holdings in shares of Centene by 3.1% in the first quarter. 180 Wealth Advisors LLC now owns 6,683 shares of the company’s stock worth $219,000 after buying an additional 199 shares during the last quarter. Summitry LLC increased its stake in shares of Centene by 1.1% during the first quarter. Summitry LLC now owns 23,925 shares of the company’s stock worth $783,000 after purchasing an additional 253 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Centene by 2.4% in the 2nd quarter. GAMMA Investing LLC now owns 10,674 shares of the company’s stock worth $685,000 after buying an additional 253 shares during the last quarter. Kestra Advisory Services LLC lifted its holdings in Centene by 0.5% in the 4th quarter. Kestra Advisory Services LLC now owns 52,602 shares of the company’s stock valued at $2,165,000 after purchasing an additional 264 shares in the last quarter. Finally, CX Institutional increased its holdings in shares of Centene by 3.1% in the second quarter. CX Institutional now owns 8,999 shares of the company’s stock valued at $578,000 after purchasing an additional 269 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Performance

CNC opened at $64.24 on Friday. The stock’s 50 day simple moving average is $64.96 and its 200 day simple moving average is $52.31. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. The stock has a market cap of $31.73 billion, a P/E ratio of -6.15, a P/E/G ratio of 0.35 and a beta of 1.08. Centene Corporation has a 1-year low of $28.24 and a 1-year high of $69.36.

Centene (NYSE:CNC – Get Free Report) last announced its earnings results on Monday, July 27th. The company reported $2.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $1.42. The company had revenue of $53.58 billion during the quarter, compared to analysts’ expectations of $47.64 billion. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.16) earnings per share. As a group, equities analysts anticipate that Centene Corporation will post 4.89 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Zacks Research upgraded Centene from a “hold” rating to a “strong-buy” rating in a report on Wednesday, July 29th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $79.00 price objective (up from $68.00) on shares of Centene in a report on Monday, August 3rd. Stifel Nicolaus set a $79.00 price objective on Centene in a research report on Monday, August 3rd. UBS Group set a $79.00 price target on shares of Centene in a research report on Tuesday. Finally, Bank of America increased their target price on shares of Centene from $72.00 to $74.00 and gave the stock a “buy” rating in a research note on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $70.05.

View Our Latest Report on CNC

Insider Buying and Selling at Centene

In related news, General Counsel Christopher Koster sold 47,603 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $65.36, for a total value of $3,111,332.08. Following the completion of the sale, the general counsel directly owned 305,354 shares of the company’s stock, valued at $19,957,937.44. The trade was a 13.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.37% of the company’s stock.

Centene Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.